Нери Лауфер

Научные публикации

• Pretreatment HIV-1 Resistance in Argentina: Results from the Second Surveillance Study Following World Health Organization Guidelines (2019)
• Markers of Natural Killer Cell Exhaustion in HIV/HCV Coinfection and Their Dynamics After HCV Clearance Mediated by Direct-Acting Antivirals
• Humoral and T Cell Response to SARS-CoV-2 Vaccination in Patients With Rheumatoid Arthritis
• Serological response to SARS-CoV-2 vaccines in patients with multiple sclerosis in Argentina
• Increased risk of false-positive HIV ELISA results after COVID-19
• Persistent symptoms after COVID-19 in children and adolescents from Argentina
• Effect of implementation of mental health services within primary care on GP detection and treatment of mental disorders in Israel
• Macrophage Migration Inhibitory Factor (MIF) Promotes Increased Proportions of the Highly Permissive Th17-like Cell Profile during HIV Infection
• Immune Response to SARS-CoV-2 Third Vaccine in Patients With Rheumatoid Arthritis Who Had No Seroconversion After Primary 2-Dose Regimen With Inactivated or Vector-Based Vaccines
• Antibody response against SARS-CoV-2 variants of concern in children infected with pre-Omicron variants: An observational cohort study
• A Dynamic Interplay of Circulating Extracellular Vesicles and Galectin-1 Reprograms Viral Latency during HIV-1 Infection
• SARS-CoV-2 humoral and cellular immune responses in COVID-19 convalescent individuals with HIV
• Longitudinal Study after Sputnik V Vaccination Shows Durable SARS-CoV-2 Neutralizing Antibodies and Reduced Viral Variant Escape to Neutralization over Time
• Pre-cART Immune Parameters in People Living With HIV Might Help Predict CD8+ T-Cell Characteristics, Inflammation Levels, and Reservoir Composition After Effective cART
• Infants Younger Than 6 Months Infected With SARS-CoV-2 Show the Highest Respiratory Viral Loads
• A Possible Sterilizing Cure of HIV-1 Infection Without Stem Cell Transplantation
• Dynamics of SARS-CoV-2-specific antibodies among COVID19 biobank donors in Argentina
• Sputnik V vaccine elicits seroconversion and neutralizing capacity to SARS-CoV-2 after a single dose
• Immune variations throughout the course of tuberculosis treatment and its relationship with adrenal hormone changes in HIV-1 patients co-infected with Mycobacterium tuberculosis
• Hepatitis C Virus (HCV) Clearance After Treatment With Direct-Acting Antivirals in Human Immunodeficiency Virus (HIV)-HCV Coinfection Modulates Systemic Immune Activation and HIV Transcription on Antiretroviral Therapy
• Cancer in IVF patients treated at age 40 years and older: long term follow-up
• 7-oxo-DHEA enhances impaired M. tuberculosis-specific T cell responses during HIV-TB coinfection
• Reprint of: Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment
• 25 historic papers: an ASRM 75th birthday gift from Fertility and Sterility
• Liver cirrhosis in HIV/HCV-coinfected individuals is related to NK cell dysfunction and exhaustion, but not to an impaired NK cell modulation by CD4⁺ T-cells
• Impact of HIV-ART on the restoration of Th17 and Treg cells in blood and female genital mucosa
• HOW DID ISRAEL BECOME AN "IVF NATION": 40 YEARS SINCE LOUISE BROWN'S BIRTH, THE FIRST IN VITRO FERTILIZATION BABY
• Phenotype, Polyfunctionality, and Antiviral Activity of in vitro Stimulated CD8⁺ T-Cells From HIV⁺ Subjects Who Initiated cART at Different Time-Points After Acute Infection
• PD-1 Expression in HIV-Specific CD8+ T cells Before Antiretroviral Therapy Is Associated With HIV Persistence
• Forty years of IVF
• Increased incidence of preeclampsia in mothers of advanced age conceiving by oocyte donation
• Biomarkers of Progression after HIV Acute/Early Infection: Nothing Compares to CD4⁺ T-cell Count?
• Introduction: Cancer biomarkers and fertility
• BRCA mutations and reproduction
• Recombinant luteinizing hormone supplementation to recombinant follicle stimulating hormone therapy in gonadotropin releasing hormone analogue cycles: what is the evidence?
• Phylogenetic Diversity in Core Region of Hepatitis C Virus Genotype 1a as a Factor Associated with Fibrosis Severity in HIV-1-Coinfected Patients
• Evaluation of Different Parameters of Humoral and Cellular Immune Responses in HIV Serodiscordant Heterosexual Couples: Humoral Response Potentially Implicated in Modulating Transmission Rates
• CD4⁺ T cells and natural killer cells: Biomarkers for hepatic fibrosis in human immunodeficiency virus/hepatitis C virus-coinfected patients
• Extrahepatic manifestations of HCV: the role of direct acting antivirals
• Expansion of CD25-Negative Forkhead Box P3-Positive T Cells during HIV and Mycobacterium tuberculosis Infection
• Flow cytometry based rapid duplexed immunoassay for fusarium mycotoxins
• Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease
• Factors associated with choice of approach for Group B streptococcus screening
• The milk we drink, food for thought
• Evolution of hepatitis C virus in HIV coinfected patients under antiretroviral therapy
• Modification of the HIV-specific CD8+ T-cell response in an HIV elite controller after chikungunya virus infection
• Introduction: Imaging in reproduction
• Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention
• Risk Related to Pre-Diabetes Mellitus and Diabetes Mellitus in Heart Failure With Reduced Ejection Fraction: Insights From Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial
• Env-Specific IgA from Viremic HIV-Infected Subjects Compromises Antibody-Dependent Cellular Cytotoxicity